Niger Health Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Funding
• Alerts
• Clinical Trials
• Forums

Evaluation of Additional Treatments for COVID-19: a Randomized Trial in Niger
Condition:   Covid-19 Interventions:   Drug: Lopinavir-Ritonavir Drug Combination;   Combination Product: Standard Care Sponsors:   Epicentre;   Université Abdou Moumouni;   Centre de Recherche Médicale et Sanitaire;   Ministry of Public Health, Republic of Niger Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 1, 2020 Category: Research Source Type: clinical trials